Avita Medical | 1811094D - Market Capitalization

Stock Price
1.14
Daily Change
-0.08 -6.58%
Monthly
7.08%
Yearly
-62.29%
Q1 Forecast
1.19

Avita Medical reported AUD149.45M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Celltrion KRW 40.04T 3.19T Sep/2025
Clinuvel Pharmaceuticals AUD 520.28M 83.45M Jun/2025
Cochlear AUD 19.65B 679.76M Jun/2025
CSL USD 76.3B 60.04B Jun/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.63T 116.94B Feb/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Mayne Pharma AUD 406.23M 2.44M Jun/2025
Medical Developments International AUD 61.96M 16.34M Jun/2025
Nanosonics AUD 1.23B 316.03M Jun/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Pacific Edge NZD 194.21M 87.84M Dec/2025
Paradigm Biopharmaceuticals AUD 118.78M 27.21M Jun/2025
Pharma Mar EUR 1.63B 241.7M Sep/2025
Polynovo AUD 825.56M 583.76M Jun/2025
PYC Therapeutics AUD 755.32M 139.4M Jun/2025
Qiagen NV USD 9.6B 89.01M Feb/2026
ResMed USD 39.31B 13.21B Feb/2026
Sartorius EUR 8.36B 8.04B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025
Telix Pharmaceuticals AUD 10.88B 2.64B Jun/2025
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025